Literature DB >> 27143665

Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients.

Salvatore Sollima1, Antonio D'Avolio2, Dario Cattaneo3, Valeria Micheli4, Laura Milazzo1, Cristina Gervasoni1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27143665     DOI: 10.1093/cid/ciw292

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  1 in total

1.  Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses.

Authors:  Jennifer R King; Amit Khatri; Roger Trinh; Rolando M Viani; Bifeng Ding; Jiuhong Zha; Rajeev Menon
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.